Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP Intraovarian Infusion for Poor Ovarian Response
NCT05181748Phase 3Recruiting
- Sponsor
- Genesis Athens Clinic
- Start
- Jan 2019
- Primary completion
- Dec 2027
- Modality
- Recombinant Proteins and Enzymes, Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of autologous platelet-rich plasma in poor ovarian response (POR), sponsored by Genesis Athens Clinic. Started Jan 2019; status: recruiting.
02
Drugs
autologous platelet-rich plasma
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on NCT05181748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05181748.